CPR serves the pharmaceutical and biotechnology industry by combining advanced analytical instrumentation with superior technical expertise. We develop, validate, and perform sample analysis in support of clinical, pre-clinical, and discovery studies in a stringent GLP environment. We provide rapid turnaround for Phase I and bioequivalence studies.

We have core competencies in small molecule and peptide analysis utilising state of the art LC/MS/MS technology. Our depth of experience translates into shorter turnaround times for method development and more rugged LC/MS/MS assays.

Our services include:

• GLP bioanalytical services
• Method development
• Method validation
• Method transfer
• Dose formulation analysis
• Clinical, pre-clinical and discovery sample analysis
• TK/PK analysis and reporting

Studies we have supported include:

• Pharmacokinetic
• Toxicokinetic
• ADME
• Bioavailability
• Bioequivalence
• Drug interaction
• Phase I to IV
• Post marketing